Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21CIP expression
- 1 August 2000
- journal article
- Published by Oxford University Press (OUP) in Carcinogenesis: Integrative Cancer Research
- Vol. 21 (8) , 1619-1622
- https://doi.org/10.1093/carcin/21.8.1619
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Polyethylene-glycol, a potent suppressor of azoxymethane-induced colonic aberrant crypt foci in ratsCarcinogenesis: Integrative Cancer Research, 1999
- Differential Effects on Growth, Cell Cycle Arrest, and Induction of Apoptosis by Resveratrol in Human Prostate Cancer Cell LinesExperimental Cell Research, 1999
- Resveratrol, a natural product derived from grape, exhibits antiestrogenic activity and inhibits the growth of human breast cancer cellsJournal of Cellular Physiology, 1999
- Resveratrol, a Natural Product Present in Wine, Decreases Tumour Growth in a Rat Tumour ModelBiochemical and Biophysical Research Communications, 1999
- Fasting/re-feeding before initiation enhances the growth of aberrant crypt foci induced by azoxymethane in rat colon and rectumInternational Journal of Cancer, 1998
- Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from GrapesScience, 1997
- Inhibition of human LDL oxidation by resveratrolThe Lancet, 1993
- An Antiplatelet Principle ofVeratrum formosanumPlanta Medica, 1992
- Wine, alcohol, platelets, and the French paradox for coronary heart diseaseThe Lancet, 1992
- Expression of a stilbene synthase gene in Nicotiana tabacum results in synthesis of the phytoalexin resveratrolPlant Molecular Biology, 1990